Medical Editorial Board

Dr. Stephen Dusza is a biostatistician and epidemiologist in the Department of Dermatology at Memorial Sloan Kettering Cancer Center in New York, where his work centers on skin cancer detection, dermoscopy, and melanoma risk. He has published over 100 scientific articles in the field of skin cancer and dermatology, spanning topics from UV exposure and melanoma epidemiology to artificial intelligence in dermoscopic image analysis and sentinel lymph node risk modeling. His research contributes to the evidence base used to validate emerging diagnostic technologies and improve early detection strategies for skin cancer.

Dr. Laura Ferris is Chair of the Department of Dermatology at UNC-Chapel Hill and holds the Clayton E. Wheeler, Jr. Distinguished Professorship. She earned her M.D. from the University of Maryland and her Ph.D. in immunology from Johns Hopkins, and completed her dermatology residency and cutaneous oncology fellowship at the University of Pittsburgh, where she previously served as clinical vice chair of dermatology and director of clinical trials at UPMC. Her clinical and research focus spans pigmented lesions and melanoma as well as psoriasis, with an emphasis on improving melanoma early detection through screening and novel diagnostic technologies.

Dr. Yaser Homsi is a medical oncologist and hematologist at Hoag Family Cancer Institute, triple board certified in hematology, medical oncology, and internal medicine. He earned his medical degree from the University of Aleppo and completed his residency and fellowship in oncology, hematology, and blood and bone marrow stem cell transplantation at Indiana University School of Medicine. Prior to joining Hoag, he served as an assistant clinical professor at City of Hope, and his research focuses on novel immunotherapy approaches to cancer treatment.

Dr. Vernon Sondak is Chair of the Department of Cutaneous Oncology at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, where he holds the Richard M. Schulze Family Foundation Distinguished Endowed Chair in Cutaneous Oncology. He is a Professor in the Departments of Oncologic Sciences and Surgery at the University of South Florida Morsani College of Medicine and has been a leader in the surgical treatment of melanoma and other cutaneous malignancies, particularly the application of sentinel lymph node biopsy to melanoma staging. Since joining Moffitt in 2004, he has helped build its Cutaneous Oncology Clinic into one of the world's leading multidisciplinary treatment centers for melanoma. He is the author or coauthor of hundreds of peer-reviewed publications.

Dr. David Swanson is a Professor of Dermatology and Residency Program Director at Mayo Clinic Arizona, board certified in both Dermatology and Internal Medicine. He serves on the Executive Board of the International Dermoscopy Society and has spent two decades as editor of Practical Reviews in Dermatology. His clinical and research interests center on high-risk skin cancer monitoring, dermoscopy, and melanoma epidemiology, with more than 50 publications and international lectures on skin cancer detection and therapy.

Dr. Thomas Wang is a board-certified surgical oncologist and Medical Director of the Hoag Melanoma/Advanced Skin Cancer Program at Hoag Family Cancer Institute. He joins Hoag after 15 years at the University of Alabama at Birmingham, where he served as Professor of Surgery and Chief of Surgical Oncology for the Birmingham VA Medical Center. He completed his surgical oncology fellowship at MD Anderson Cancer Center and has published over 40 peer-reviewed manuscripts, with clinical interests in melanoma, soft tissue sarcomas, and endocrine surgery.